SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-23-002595
Filing Date
2023-03-01
Accepted
2023-03-01 16:39:48
Documents
115
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tbph-20221231x10k.htm   iXBRL 10-K 3671795
2 EX-10.72 tbph-20221231xex10d72.htm EX-10.72 269524
3 EX-10.77 tbph-20221231xex10d77.htm EX-10.77 56367
4 EX-21.1 tbph-20221231xex21d1.htm EX-21.1 3295
5 EX-23.1 tbph-20221231xex23d1.htm EX-23.1 4421
6 EX-23.2 tbph-20221231xex23d2.htm EX-23.2 2625
7 EX-31.1 tbph-20221231xex31d1.htm EX-31.1 10369
8 EX-31.2 tbph-20221231xex31d2.htm EX-31.2 10376
9 EX-32 tbph-20221231xex32.htm EX-32 14979
10 GRAPHIC tbph-20221231x10k006.jpg GRAPHIC 32151
11 GRAPHIC tbph-20221231x10k007.jpg GRAPHIC 19905
12 GRAPHIC tbph-20221231x10k008.jpg GRAPHIC 18694
13 GRAPHIC tbph-20221231x10k009.jpg GRAPHIC 3307
14 GRAPHIC tbph-20221231x10k010.jpg GRAPHIC 9363
15 GRAPHIC tbph-20221231x10k012.jpg GRAPHIC 97165
  Complete submission text file 0001558370-23-002595.txt   15736050

Data Files

Seq Description Document Type Size
16 EX-101.SCH tbph-20221231.xsd EX-101.SCH 92394
17 EX-101.CAL tbph-20221231_cal.xml EX-101.CAL 90023
18 EX-101.DEF tbph-20221231_def.xml EX-101.DEF 453973
19 EX-101.LAB tbph-20221231_lab.xml EX-101.LAB 801114
20 EX-101.PRE tbph-20221231_pre.xml EX-101.PRE 666167
109 EXTRACTED XBRL INSTANCE DOCUMENT tbph-20221231x10k_htm.xml XML 2918400
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36033 | Film No.: 23694285
SIC: 2834 Pharmaceutical Preparations